Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
3 pending office actions • 2 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
The Academy Of Military Medical Sciences has 3 pending office actions in the Chemistry & Materials technology area. These actions are distributed among 3 distinct examiners. This distribution ensures that each pending matter is being reviewed by a different person, which can lead to a variety of examination experiences across the portfolio. The organization's reliance on multiple examiners suggests that its current filings are not being funneled through a single point of contact.
The portfolio involves 2 distinct art units. This suggests that the examiners are working in closely related technical fields within the 2 distinct art units. This technical clustering might provide some predictability in the types of rejections or prior art cited. YAMASAKI, ROBERT J is the busiest examiner, with 1 pending office action. This examiner's workload is equal to the others assigned to the 1 pending office action per person distribution.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (33%) |
| Multi-statute (no §101) | 2 (67%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| YAMASAKI, ROBERT J | 1 | 67.6% | +43.7% |
| EDWARDS, LYDIA E | 1 | 60.2% | +5.8% |
| LEE, WILLIAM Y | 1 | 47.9% | +34.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18730739 | METHOD FOR SCREENING ACETYLCHOLINESTERASE INHIBITOR | YAMASAKI, ROBERT J | — |
| 17378415 | USE OF SUBSTITUTED AMINOPROPIONATE COMPOUNDS IN TREATMENT OF SARS-COV-2 INFECTION | LEE, WILLIAM Y | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18730739 | METHOD FOR SCREENING ACETYLCHOLINESTERASE INHIBITOR | YAMASAKI, ROBERT J | — |
| 17378415 | USE OF SUBSTITUTED AMINOPROPIONATE COMPOUNDS IN TREATMENT OF SARS-COV-2 INFECTION | LEE, WILLIAM Y | — |
| Art Unit | Apps |
|---|---|
| 1796 | 1 |
| 1623 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18730739 | METHOD FOR SCREENING ACETYLCHOLINESTERASE INHIBITOR | YAMASAKI, ROBERT J | — | §103§112 | Non-Final OA | — | Pending | Jul 19, 2024 |
| 17627747 | SYSTEM AND METHOD FOR PREPARING MRNA | EDWARDS, LYDIA E | 1796 | §112 | Final Rejection | 5d overdue | Pending | Jan 17, 2022 |
| 17378415 | USE OF SUBSTITUTED AMINOPROPIONATE COMPOUNDS IN TREATMENT OF SARS-COV-2 INFECTION | LEE, WILLIAM Y | 1623 | §103§112 | Non-Final OA | — | Pending | Jul 16, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial